Article
Germline DNA Sequencing Reveals Novel Mutations Predictive of Overall Survival in a Cohort of Patients with Pancreatic Cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research - 15 Mar 2020
Goldstein Jennifer B, Zhao Li, Wang Xuemei, Ghelman Yael, Overman Michael J, Javle Milind M, Shroff Rachna T, Varadhachary Gauri R, Wolff Robert A, McAllister Florencia, Futreal Andrew, Fogelman David R
Abstract excerpt
PURPOSE: Family history of BRCA-related tumors may correlate with response to chemotherapy and overall survival (OS) in pancreatic cancer. The frequency of germline mutations has been reported in patients predominantly under the age of 60 or with strong family history. We examine the incidence of deleterious germline mutations and compare the chemotherapy responses and OS in an unselected group of patients with...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
